Gala, Nichole .
HRN: 21-61-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFUROXIME 1.5GM (VIAL)
04/20/2024
04/21/2024
IV
1.5 Gram
Q8 X 3 Doses
SP LTCS W IUD Insertion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes